Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Agile Therapeutics Inc (AGRX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Agile Therapeutics Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1261249.
Total stock buying since 2014: $79,257,273.
Total stock sales since 2014: $2,369,943.
Total stock option exercises since 2014: $436,190.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2022 | 50,000 | $22,500 | 0 | $0 | 0 | $0 |
2021 | 6,030,908 | $5,148,339 | 0 | $0 | 0 | $0 |
2020 | 4,094,000 | $10,977,875 | 0 | $0 | 165,289 | $273,540 |
2019 | 8,133,815 | $12,012,995 | 4,575,640 | $2,280,355 | 147,554 | $0 |
2018 | 0 | $0 | 298,628 | $89,588 | 194,361 | $0 |
2017 | 80,583 | $289,052 | 0 | $0 | 53,667 | $79,050 |
2016 | 393,700 | $2,499,995 | 0 | $0 | 16,666 | $0 |
2015 | 1,626,432 | $9,521,827 | 0 | $0 | 17,500 | $30,800 |
2014 | 6,464,115 | $38,784,690 | 0 | $0 | 30,000 | $52,800 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2022-08 | 50,000 | $22,500 | 0 | $0 | 0 | $0 |
2021-10 | 5,852,208 | $4,874,376 | 0 | $0 | 0 | $0 |
2021-07 | 76,200 | $87,240 | 0 | $0 | 0 | $0 |
2021-05 | 40,000 | $59,200 | 0 | $0 | 0 | $0 |
2021-03 | 62,500 | $127,523 | 0 | $0 | 0 | $0 |
2020-11 | 0 | $0 | 0 | $0 | 4,149 | $7,302 |
2020-09 | 9,000 | $25,650 | 0 | $0 | 0 | $0 |
2020-08 | 0 | $0 | 0 | $0 | 94,599 | $166,494 |
2020-06 | 0 | $0 | 0 | $0 | 50,000 | $88,000 |
2020-03 | 1,075,000 | $1,925,125 | 0 | $0 | 0 | $0 |
2020-02 | 3,010,000 | $9,027,100 | 0 | $0 | 16,541 | $11,744 |
2019-11 | 5,768,815 | $9,733,295 | 0 | $0 | 0 | $0 |
2019-10 | 0 | $0 | 4,575,640 | $2,280,355 | 0 | $0 |
2019-08 | 2,300,000 | $2,185,000 | 0 | $0 | 0 | $0 |
2019-06 | 20,000 | $25,400 | 0 | $0 | 0 | $0 |
2019-03 | 45,000 | $69,300 | 0 | $0 | 0 | $0 |
2019-01 | 0 | $0 | 0 | $0 | 147,554 | $0 |
2018-07 | 0 | $0 | 298,628 | $89,588 | 0 | $0 |
2018-06 | 0 | $0 | 0 | $0 | 107,694 | $0 |
2018-02 | 0 | $0 | 0 | $0 | 16,667 | $0 |
2018-01 | 0 | $0 | 0 | $0 | 70,000 | $0 |
2017-08 | 17,250 | $57,687 | 0 | $0 | 0 | $0 |
2017-06 | 0 | $0 | 0 | $0 | 7,000 | $26,250 |
2017-05 | 63,333 | $231,365 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-08-26 | Altomari Alfred (Chief Executive Officer) | Buy | 50,000 | .45 | 22,500 |
2021-10-13 | Reilly Dennis (Chief Financial Officer) | Buy | 58,824 | .00 | 0 |
2021-10-13 | Altomari Alfred (Chief Executive Officer) | Buy | 58,824 | .00 | 0 |
2021-10-13 | Edelman Joseph (10% Owner) | Buy | 5,734,560 | .85 | 4,874,376 |
2021-07-29 | Altomari Alfred (Chief Executive Officer) | Buy | 26,200 | 1.26 | 33,090 |
2021-07-27 | Reilly Dennis (Chief Financial Officer) | Buy | 50,000 | 1.08 | 54,150 |
2021-05-18 | Altomari Alfred (Chief Executive Officer) | Buy | 20,000 | 1.61 | 32,200 |
2021-05-11 | Reilly Dennis (Chief Financial Officer) | Buy | 20,000 | 1.35 | 27,000 |
2021-03-23 | Reilly Dennis (Chief Financial Officer) | Buy | 50,000 | 2.05 | 102,499 |
2021-03-23 | Altomari Alfred (Chief Executive Officer) | Buy | 12,500 | 2.00 | 25,024 |
2020-11-19 | Conway Robert G (SVP Chief Supply Chain Officer) | Option Ex | 4,149 | 1.76 | 7,302 |
2020-09-28 | Reilly Dennis (Chief Financial Officer) | Buy | 9,000 | 2.85 | 25,650 |
2020-08-20 | Altomari Alfred (Chief Executive Officer) | Option Ex | 94,599 | 1.76 | 166,494 |
2020-06-22 | Altomari Alfred (Chief Executive Officer) | Option Ex | 50,000 | 1.76 | 88,000 |
2020-03-13 | Edelman Joseph (10% Owner) | Buy | 1,000,000 | 1.75 | 1,750,000 |
2020-03-04 | Reilly Dennis (Chief Financial Officer) | Buy | 75,000 | 2.33 | 175,125 |
2020-02-27 | Altomari Alfred (Chief Executive Officer) | Buy | 10,000 | 2.71 | 27,100 |
2020-02-27 | Altomari Alfred (Chief Executive Officer) | Option Ex | 16,541 | .71 | 11,744 |
2020-02-25 | Edelman Joseph (10% Owner) | Buy | 3,000,000 | 3.00 | 9,000,000 |
2019-11-15 | Edelman Joseph (10% Owner) | Buy | 5,333,800 | 1.69 | 8,998,120 |
2019-11-14 | Edelman Joseph (10% Owner) | Buy | 435,015 | 1.69 | 735,175 |
2019-10-29 | Edelman Joseph (10% Owner) | Sale | 760,291 | .44 | 334,528 |
2019-10-28 | Edelman Joseph (10% Owner) | Sale | 3,815,349 | .51 | 1,945,827 |
2019-08-06 | Edelman Joseph (10% Owner) | Buy | 2,300,000 | .95 | 2,185,000 |
2019-06-10 | Altomari Alfred (Chief Executive Officer) | Buy | 20,000 | 1.27 | 25,400 |
2019-03-29 | Lele Abhijeet J (Director) | Buy | 20,000 | 1.54 | 30,800 |
2019-03-25 | Altomari Alfred (Chief Executive Officer) | Buy | 25,000 | 1.54 | 38,500 |
2019-01-25 | Garner Elizabeth (Sr. VP & Chief Medical Officer) | Option Ex | 17,500 | .00 | 0 |
2019-01-25 | Coiante Scott M (Chief Financial Officer) | Option Ex | 17,500 | .00 | 0 |
2019-01-25 | Gilmore Geoffrey (General Counsel) | Option Ex | 17,500 | .00 | 0 |
2019-01-24 | Conway Robert G (SVP Ent Planning & Info Mgt) | Option Ex | 8,625 | .00 | 0 |
2019-01-24 | Garner Elizabeth (Sr. VP & Chief Medical Officer) | Option Ex | 18,565 | .00 | 0 |
2019-01-24 | Coiante Scott M (Chief Financial Officer) | Option Ex | 16,070 | .00 | 0 |
2019-01-24 | Gilmore Geoffrey (General Counsel) | Option Ex | 16,480 | .00 | 0 |
2019-01-24 | Altomari Alfred (Chief Executive Officer) | Option Ex | 35,314 | .00 | 0 |
2018-07-26 | Edelman Joseph (Other) | Sale | 298,628 | .30 | 89,588 |
2018-06-08 | Shetty Ajit (Director) | Option Ex | 17,949 | .00 | 0 |
2018-06-08 | Hubbard John W (Director) | Option Ex | 17,949 | .00 | 0 |
2018-06-08 | Fischer Seth H. Z. (Director) | Option Ex | 17,949 | .00 | 0 |
2018-06-08 | Tursi James Patrick (Director) | Option Ex | 17,949 | .00 | 0 |
2018-06-08 | Lele Abhijeet J (Director) | Option Ex | 17,949 | .00 | 0 |
2018-06-08 | Mckee William (Director) | Option Ex | 17,949 | .00 | 0 |
2018-02-08 | Altomari Alfred (Chief Executive Officer) | Option Ex | 16,667 | .00 | 0 |
2018-01-25 | Selman Renee (Chief Commercial Officer) | Option Ex | 17,500 | .00 | 0 |
2018-01-25 | Garner Elizabeth (Sr. VP & Chief Medical Officer) | Option Ex | 17,500 | .00 | 0 |
2018-01-25 | Coiante Scott M (Chief Financial Officer) | Option Ex | 17,500 | .00 | 0 |
2018-01-25 | Gilmore Geoffrey (General Counsel) | Option Ex | 17,500 | .00 | 0 |
2017-08-25 | Selman Renee (Chief Commercial Officer) | Buy | 7,250 | 3.35 | 24,287 |
2017-08-25 | Altomari Alfred (Chairman & Chief Executive Officer) | Buy | 10,000 | 3.34 | 33,400 |
2017-06-12 | Shetty Ajit (Director) | Option Ex | 7,000 | 3.75 | 26,250 |
2017-05-11 | Selman Renee (Chief Commercial Officer) | Buy | 53,333 | 3.68 | 196,265 |
2017-05-11 | Altomari Alfred (Chairman and Chief Executive O) | Buy | 10,000 | 3.51 | 35,100 |
2017-04-11 | Altomari Alfred (Chairman & Chief Exec Officer) | Option Ex | 30,000 | 1.76 | 52,800 |
2017-02-08 | Altomari Alfred (Chief Executive Officer) | Option Ex | 16,667 | .00 | 0 |
2016-02-08 | Altomari Alfred (Chief Executive Officer) | Option Ex | 16,666 | .00 | 0 |
2016-01-27 | Proquest Associates Iv Llc (10% Owner) | Buy | 393,700 | 6.35 | 2,499,995 |
2015-06-02 | Altomari Alfred (Chief Executive Officer) | Buy | 2,500 | 8.73 | 21,825 |
2015-03-11 | Altomari Alfred (Chief Executive Officer) | Option Ex | 17,500 | 1.76 | 30,800 |
2015-01-23 | Proquest Associates Iv Llc (10% Owner) | Buy | 811,966 | 5.85 | 4,750,001 |
2015-01-23 | Schiff Andrew N | Buy | 811,966 | 5.85 | 4,750,001 |
2014-12-18 | Altomari Alfred (Chief Executive Officer) | Option Ex | 30,000 | 1.76 | 52,800 |
2014-05-29 | Care Capital Offshore Investments Iii Lp (10% Owner) | Buy | 500,000 | 6.00 | 3,000,000 |
2014-05-29 | Proquest Associates Iv Llc (10% Owner) | Buy | 1,120,833 | 6.00 | 6,724,998 |
2014-05-29 | Investor Ab | Buy | 2,509,949 | 6.00 | 15,059,694 |
2014-05-23 | Schiff Andrew N | Buy | 1,333,333 | 6.00 | 7,999,998 |
2014-05-22 | Investor Ab | Buy | 1,000,000 | 6.00 | 6,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of AGRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Agile Therapeutics Inc (symbol AGRX, CIK number 1261249) see the Securities and Exchange Commission (SEC) website.